Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruption.
Janowicz PW, Houston ZH, Bunt J, Fletcher NL, Bell CA, Cowin G, Howard CB, Taslima D, Westra van Holthe N, Prior A, Soh V, Ghosh S, Humphries J, Huda P, Mahler SM, Richards LJ, Thurecht KJ.
Janowicz PW, et al. Among authors: howard cb.
Biomaterials. 2022 Apr;283:121416. doi: 10.1016/j.biomaterials.2022.121416. Epub 2022 Feb 17.
Biomaterials. 2022.
PMID: 35217483